Anti-cancer drug development: Computational strategies to identify and target proteins involved in cancer metabolism

Lora Mak, Sonia Liggi, Lu Tan, Kanthida Kusonmano, Judith M. Rollinger, Alexios Koutsoukas, Robert C. Glen, Johannes Kirchmair

    Publications: Contribution to journalReviewPeer Reviewed

    Abstract

    Cancer remains a fundamental burden to public health despite substantial efforts aimed at developing effective chemotherapeutics and significant advances in chemotherapeutic regimens. The major challenge in anti-cancer drug design is to selectively target cancer cells with high specificity. Research into treating malignancies by targeting altered metabolism in cancer cells is supported by computational approaches, which can take a leading role in identifying candidate targets for anti-cancer therapy as well as assist in the discovery and optimisation of anti-cancer agents. Natural products appear to have privileged structures for anti-cancer drug development and the bulk of this particularly valuable chemical space still remains to be explored. In this review we aim to provide a comprehensive overview of current strategies for computer-guided anti-cancer drug development. We start with a discussion of state-of-the art bioinformatics methods applied to the identification of novel anti-cancer targets, including machine learning techniques, the Connectivity Map and biological network analysis. This is followed by an extensive survey of molecular modelling and cheminformatics techniques employed to develop agents targeting proteins involved in the glycolytic, lipid, NAD+, mitochondrial (TCA cycle), amino acid and nucleic acid metabolism of cancer cells. A dedicated section highlights the most promising strategies to develop anti-cancer therapeutics from natural products and the role of metabolism and some of the many targets which are under investigation are reviewed. Recent success stories are reported for all the areas covered in this review. We conclude with a brief summary of the most interesting strategies identified and with an outlook on future directions in anti-cancer drug development.

    Original languageEnglish
    Pages (from-to)532-577
    Number of pages46
    JournalCurrent Pharmaceutical Design
    Volume19
    Issue number4
    DOIs
    Publication statusPublished - 2013

    Austrian Fields of Science 2012

    • 301204 Pharmacognosy
    • 301201 Pharmaceutical and drug analysis

    Keywords

    • Anti-cancer drugs
    • Anti-metabolites
    • Bioinformatics
    • Cancer
    • Cheminformatics
    • Chemotherapy
    • Computational model
    • Metabolism
    • Molecular modelling
    • Natural products

    Cite this